Devangi S Mehta

Summary

Publications

  1. ncbi Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice
    Devangi S Mehta
    Tolerx, Inc, Cambridge, MA 02139 3515, USA
    Immunology 130:103-13. 2010

Collaborators

Detail Information

Publications1

  1. ncbi Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice
    Devangi S Mehta
    Tolerx, Inc, Cambridge, MA 02139 3515, USA
    Immunology 130:103-13. 2010
    ....